MetaCap

Lantheus Statistics

NASDAQ: LNTHHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

102.100.00 (0.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Lantheus by the numbers

Lantheus has a market capitalization of $6.68 billion based on 65.40M shares outstanding. Its trailing P/E ratio is 25.4, and its forward P/E is 15.3. The stock trades 1.6% above its 50-day average and 8.6% above its 200-day average.

Average daily trading volume is 1.02M shares, or about $104.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

LNTH valuation vs. peer median

LNTH compared with the median of 8 peer companies
MetricLNTHPeer medianDifference
Market cap$6.68B$988.42M+576%
Avg. volume1.02M1.71M-40%

Peer median across 8 companies: ORKA, NEOG, CLDX, NTLA, QUIT, QDEL, MYGN, TKNO.

Valuation

Price / sales (latest FY)
4.33

Price and trading

Previous close
102.10
Open
102.10
Day range
102.07 – 102.40
52-week range
54.94 – 111.86
52-week change
+82.91%
Beta
—
Volume
1.07M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
6.68B
Pe
25.40
Forward Pe
15.34
Eps
4.02
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
111.86
Week52 Low
54.94
Avg Volume
1.02M
Shares Outstanding
65.40M
Ma50
100.46
Ma200
94.00
Earnings Date
Nov 5, 2026
Pct From52w High
-8.73%
Pct From52w Low
85.84%

Related